🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/09/2016 7,12 7,20 6,87 6,94 -3,88% 4,63% 653.700
12/09/2016 7,01 7,28 6,80 7,22 +0,84% 6,85% 1.080.600
09/09/2016 7,66 7,66 7,13 7,16 -6,41% 6,92% 838.100
08/09/2016 7,24 7,75 7,24 7,65 +4,22% 7,04% 873.600
07/09/2016 7,20 7,36 7,10 7,34 +2,51% 3,61% 550.400
06/09/2016 7,09 7,37 7,09 7,16 +0,14% 3,95% 528.100
02/09/2016 7,12 7,32 7,01 7,15 +1,27% 4,28% 504.400
01/09/2016 6,85 7,08 6,83 7,06 +1,88% 3,77% 465.700
31/08/2016 7,03 7,13 6,73 6,93 -2,12% 5,69% 923.900
30/08/2016 6,83 7,47 6,83 7,08 +2,76% 9,37% 1.073.700
29/08/2016 6,83 6,95 6,60 6,89 -0,86% 5,12% 767.200
26/08/2016 6,87 7,11 6,82 6,95 +1,02% 4,22% 737.200
25/08/2016 6,95 7,30 6,70 6,88 -0,15% 8,63% 1.282.000
24/08/2016 8,20 8,22 6,68 6,89 -14,73% 18,78% 3.090.400
23/08/2016 7,83 8,22 7,82 8,08 +4,26% 5,11% 1.589.700
22/08/2016 7,58 8,00 7,40 7,75 +3,33% 7,92% 1.316.300
19/08/2016 7,14 7,73 7,00 7,50 +6,23% 10,22% 2.233.500
18/08/2016 6,67 7,20 6,60 7,06 +11,36% 9,00% 3.047.800
17/08/2016 6,14 6,35 6,09 6,34 +2,76% 4,23% 577.200
16/08/2016 6,08 6,30 6,07 6,17 +0,82% 3,73% 646.100
15/08/2016 5,93 6,18 5,93 6,12 +2,68% 4,30% 651.200
12/08/2016 5,72 6,03 5,68 5,96 +3,83% 6,12% 553.700
11/08/2016 5,83 5,85 5,68 5,74 -1,54% 2,92% 432.700
10/08/2016 5,92 6,00 5,61 5,83 -8,76% 6,59% 1.134.700
09/08/2016 5,86 6,44 5,50 6,39 +8,31% 16,04% 2.022.100
08/08/2016 6,01 6,07 5,78 5,90 -1,50% 4,76% 281.800
05/08/2016 5,92 6,05 5,88 5,99 +1,53% 2,87% 531.000
04/08/2016 5,91 5,98 5,84 5,90 +0,17% 2,37% 324.700
03/08/2016 5,66 5,99 5,66 5,89 +2,61% 5,83% 435.400
02/08/2016 5,85 5,94 5,64 5,74 -2,05% 5,13% 382.900